Stock listing

OTC:ULGX Urologix Stock

Follow Urologix into a list and get an email when it puts out news.

Share price · OTC:ULGX

$0.0001 USD 0.0000 (0.0%)

Close on Oct 23, 2026

Past year 0.0% · daily closes, Oct 23, 2025 – Oct 23, 2026, adjusted for splits
Day range
$0.0001 – $0.0001 USDOct 23, 2026
Market cap
—Left out: too few shares trade to back it
52-week range
$0.0001 – $0.0126 USDLowest and highest trades, Oct 24, 2025 – Oct 23, 2026
Traded on an average day
$0 USDMedian day 0 shares · 63 days with no trades · last 3 months, Jul 23, 2026 – Oct 23, 2026
Urologix logo

Daily closes

Last 3 months, Jul 23, 2026 – Oct 23, 2026 · OTC:ULGX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000183,334
$0.00010.00000.0%$0.0001$0.0001$0.0001125
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001290
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001650
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
Ticker
OTC:ULGX
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

Latest news

All Urologix news

Urologix on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
9 in all · newest Jul 9, 2015 · oldest 2014
Decks
1 deck · latest Jun 13, 2012

Valuation

price Oct 23, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.00

Events

QuarterResultsShare move
Quarter to Dec 31, 2024Feb 7, 2025
Quarter to Sep 30, 2024Nov 18, 2024
Quarter to Jun 30, 2024Aug 21, 2024
Quarter to Mar 31, 2024May 15, 2024
Quarter to Dec 31, 2023Feb 9, 2024
Quarter to Sep 30, 2023Nov 1, 2023
Quarter to Jun 30, 2023Aug 23, 2023
Quarter to Mar 31, 2023May 10, 2023
Quarter to Dec 31, 2022Feb 3, 20230.0%
Quarter to Sep 30, 2022Nov 2, 2022
All 17 quarters
QuarterResultsShare move
Quarter to Jun 30, 2022Aug 17, 2022
Quarter to Mar 31, 2022May 11, 2022+100.0%
Quarter to Dec 31, 2021Feb 4, 2022
Quarter to Sep 30, 2021Oct 27, 2021
Quarter to Jun 30, 2021Aug 18, 2021+22.0%
Quarter to Mar 31, 2021May 12, 2021−12.1%
Quarter to Dec 31, 2020Feb 5, 2021+1.2%

Open Events

Decks

DeckKindSlidesDate
IPO Roadshow (June 2012)IPO roadshow24 slidesJun 13, 2012

Open Decks

Financials

Annual, in USD

Income statement

LineFY2014FY2013FY2012FY2011FY2010FY2009FY2008FY2007FY2006FY2005
Revenue14.2M16.6M17.0M12.6M14.8M12.8M14.9M21.3M25.9M25.8M
Cost of revenue8.14M8.41M8.64M6.03M6.57M6.37M6.89M13.9M8.99M7.81M
Gross profit6.09M8.18M8.38M6.54M8.20M6.45M8.01M7.42M16.9M18.0M
Research and development1.63M2.27M2.19M2.24M1.83M2.36M2.78M3.03M2.99M3.07M
Selling, general and administrative2.30M2.52M3.39M7.90M10.4M10.9M14.5M14.1M15.9M14.7M
Operating income-6.93M-3.92M-4.14M-3.73M-2.26M-4.46M-16.8M-8.93M769.0K3.12M
Depreciation and amortization587.0K674.0K695.0K565.0K793.0K973.0K1.19M2.26M2.02M1.88M
EBITDA-6.34M-3.25M-3.45M-3.16M-1.46M-3.49M-15.6M-6.67M2.78M5.00M
Interest expense693.0K555.0K482.0K0000009.00K
Income before tax-7.62M-4.28M-4.64M-3.73M-2.26M-4.41M-16.4M-8.38M1.14M3.26M
Income tax-16.0K14.0K55.0K8.00K-88.0K7.00K-1.50M4.86M-4.35M424.0K
Net income-7.61M-4.29M-4.70M-3.73M-2.17M-4.42M-14.9M-13.2M5.49M2.84M
Earnings per share, basic-0.36-0.21-0.32-0.26-0.15-0.31-1.04-0.920.380.19

Balance sheet

LineFY2014FY2013FY2012FY2011FY2010FY2009FY2008FY2007FY2006FY2005
Cash and equivalents718.0K2.29M1.90M3.06M5.70M7.03M11.0M12.3M11.1M10.6M
Short-term investments171.0K
Receivables1.50M2.13M2.13M1.36M1.38M1.50M1.77M4.07M5.23M4.24M
Inventory1.40M1.95M1.45M1.13M1.50M1.41M1.63M2.42M2.63M1.74M
Current assets3.68M6.50M5.77M5.79M8.72M10.0M14.6M18.8M20.1M17.0M
Property, plant and equipment471.0K735.0K862.0K861.0K1.01M1.41M2.01M2.33M2.90M2.45M
Goodwill3.04M3.12M10.2M10.2M10.2M
Total assets5.67M12.5M12.7M6.76M10.2M12.1M17.5M32.7M43.9M39.1M
Accounts payable892.0K628.0K3.38M741.0K434.0K462.0K774.0K948.0K1.38M1.53M
Current liabilities4.29M2.64M7.29M1.76M2.00M2.06M3.29M2.71M3.17M3.83M
Long-term debt4.59M5.33M
Total debt5.33M5.33M
Total liabilities12.6M12.1M12.1M1.92M2.00M2.22M3.63M4.78M3.92M5.96M
Shareholders' equity-6.98M420.0K626.0K4.85M8.21M9.93M13.8M27.9M40.0M33.1M
Shares outstanding21.2M20.7M14.7M14.6M14.5M14.4M14.3M14.3M14.4M14.8M

Cash flow

LineFY2014FY2013FY2012FY2011FY2010FY2009FY2008FY2007FY2006FY2005
Cash from operations-1.53M-1.96M-713.0K-2.37M-1.25M-3.92M-1.04M1.50M1.17M2.92M
Capital spending-42.0K-79.0K-57.0K-272.0K-85.0K-86.0K-213.0K-312.0K-953.0K-91.0K
Free cash flow-1.57M-2.04M-770.0K-2.64M-1.34M-4.01M-1.26M1.18M214.0K2.83M
Cash from investing-42.0K-1.48M-565.0K-275.0K-85.0K-86.0K-213.0K-312.0K-781.0K2.19M
Cash from financing3.83M116.0K4.00K10.0K8.00K39.0K12.0K69.0K348.0K
Share buybacks3.83M116.0K4.00K
Change in cash-1.57M391.0K-1.16M-2.64M-1.33M-4.00M-1.22M1.20M455.0K5.46M

Open Financials

Cap table

Built by 6ix from Urologix’s releases

Common shares
21,817,726
Fully diluted
21,817,726

Fully diluted

LineShares
Common shares21,817,726

Share count over time

CountShares
Nov 22, 202621,817,726

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Guy C Jackson
Other companies: Cyberonics Inc (Director · Jun 18, 2007 – Oct 19, 2015 · Past); Life Time Fitness Inc (Director · May 4, 2006 – Jun 10, 2015 · Past); Digi International Inc. (Director · Jan 18, 2006 – Nov 24, 2015 · Past)
Director · Nov 7, 2006 – Nov 10, 2009 · Past
Patrick D Spangler
Other companies: OptimizeRx Corporation (Director · Since at least Mar 23, 2018); Epocrates Inc (Chief Financial Officer · Feb 1, 2011 – Jan 20, 2012 · Past); ev3 Inc (Sr. VP and CFO · May 9, 2006 – Nov 15, 2008 · Past)
Director · Aug 15, 2010 – Nov 6, 2014 · Past
Sidney W Emery Jr
Other companies: AIxCrypto Holdings, Inc. (Director · Dec 7, 2020 – Jul 11, 2022 · Past); Allete Inc (Director · May 8, 2007 – Jun 1, 2018 · Past); MTS Systems Corporation (Chairman, Director · Nov 22, 2005 – Jul 30, 2008 · Past)
Director · Feb 2, 2006 – Nov 19, 2014 · Past
Kirsten Doerfert
Other companies: Axe Compute Inc. (VP of Sales and Marketing · Oct 19, 2009 – Oct 19, 2009 · Past)
Sr VP and Gen'l Mgr · Aug 23, 2007 – Oct 30, 2007 · Past
Brian J SmrdelChief Financial Officer · Aug 14, 2013 – Aug 14, 2013 · Past
Jerry C CirinoDirector · Jan 18, 2006 – Nov 11, 2008 · Past
Rebecca J WeberDir. of Finance & Controller · Apr 15, 2008 – Aug 6, 2009 · Past
Stryker Warren JrChief Executive Officer, Director · Jun 24, 2008 – Jun 29, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Urologix.